158 related articles for article (PubMed ID: 23983854)
1. The secret "spice": an undetectable toxic cause of seizure.
de Havenon A; Chin B; Thomas KC; Afra P
Neurohospitalist; 2011 Oct; 1(4):182-6. PubMed ID: 23983854
[TBL] [Abstract][Full Text] [Related]
2. The other side of the leaf: Seizures associated with synthetic cannabinoid use.
Gounder K; Dunuwille J; Dunne J; Lee J; Silbert P; Lawn N
Epilepsy Behav; 2020 Mar; 104(Pt A):106901. PubMed ID: 31958643
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.
Tait RJ; Caldicott D; Mountain D; Hill SL; Lenton S
Clin Toxicol (Phila); 2016; 54(1):1-13. PubMed ID: 26567470
[TBL] [Abstract][Full Text] [Related]
4. Synthetic Cannabinoids-"Spice" Can Induce a Psychosis: A Brief Review.
Yeruva RR; Mekala HM; Sidhu M; Lippmann S
Innov Clin Neurosci; 2019 Jan; 16(1-2):31-32. PubMed ID: 31037226
[TBL] [Abstract][Full Text] [Related]
5. Natural (∆
Malyshevskaya O; Aritake K; Kaushik MK; Uchiyama N; Cherasse Y; Kikura-Hanajiri R; Urade Y
Sci Rep; 2017 Sep; 7(1):10516. PubMed ID: 28874764
[TBL] [Abstract][Full Text] [Related]
6. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
[TBL] [Abstract][Full Text] [Related]
7. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
8. The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice.
Shafaroodi H; Samini M; Moezi L; Homayoun H; Sadeghipour H; Tavakoli S; Hajrasouliha AR; Dehpour AR
Neuropharmacology; 2004 Sep; 47(3):390-400. PubMed ID: 15275828
[TBL] [Abstract][Full Text] [Related]
9. [Spice in France: mixed herbs containing synthetic cannabinoids].
Schlatter J; Chiadmi F; Chariot P
Ann Biol Clin (Paris); 2012; 70(4):413-22. PubMed ID: 22796613
[TBL] [Abstract][Full Text] [Related]
10. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?
Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL
Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047
[TBL] [Abstract][Full Text] [Related]
11. Convulsions associated with the use of a synthetic cannabinoid product.
Schneir AB; Baumbacher T
J Med Toxicol; 2012 Mar; 8(1):62-4. PubMed ID: 22160733
[TBL] [Abstract][Full Text] [Related]
12. Seizure and Interictal Electroencephalographic (EEG) Changes with Cannabinoid Concentrate Use.
Kahan MD; Breithaupt A; Nash K; Numis AL
Am J Case Rep; 2021 Apr; 22():e931360. PubMed ID: 33866321
[TBL] [Abstract][Full Text] [Related]
13. 'Crazy Monkey' poisons man and dog: Human and canine seizures due to PB-22, a novel synthetic cannabinoid.
Gugelmann H; Gerona R; Li C; Tsutaoka B; Olson KR; Lung D
Clin Toxicol (Phila); 2014 Jul; 52(6):635-8. PubMed ID: 24905571
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice.
Naderi N; Aziz Ahari F; Shafaghi B; Najarkolaei AH; Motamedi F
J Neural Transm (Vienna); 2008 Nov; 115(11):1501-11. PubMed ID: 18575801
[TBL] [Abstract][Full Text] [Related]
15. Ischemic stroke associated with the use of a synthetic cannabinoid (spice).
Moeller S; Lücke C; Struffert T; Schwarze B; Gerner ST; Schwab S; Köhrmann M; Machold K; Philipsen A; Müller HH
Asian J Psychiatr; 2017 Feb; 25():127-130. PubMed ID: 28262132
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic Thrombocytopenic Purpura Induced by Synthetic Cannabinoid.
Castaneira G; Rojas K; Galili Y; Field Z; Perez-Perez A; Madruga M; Carlan SJ
J Addict Med; 2019; 13(3):235-236. PubMed ID: 30531235
[TBL] [Abstract][Full Text] [Related]
17. [Spice drugs: cannabinoids as a new designer drugs].
Mustata C; Torrens M; Pardo R; Pérez C; ; Farré M
Adicciones; 2009; 21(3):181-6. PubMed ID: 19718488
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Use of Synthetic Cannabinoids: Still an OpenIssue?
De Luca MA; Fattore L
Clin Ther; 2018 Sep; 40(9):1457-1466. PubMed ID: 30180974
[TBL] [Abstract][Full Text] [Related]
19. What are the psychological effects of using synthetic cannabinoids? A systematic review.
Akram H; Mokrysz C; Curran HV
J Psychopharmacol; 2019 Mar; 33(3):271-283. PubMed ID: 30789300
[TBL] [Abstract][Full Text] [Related]
20. The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in 'Spice'.
Dargan PI; Hudson S; Ramsey J; Wood DM
Int J Drug Policy; 2011 Jul; 22(4):274-7. PubMed ID: 21482092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
